{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:17:35Z","timestamp":1791220655877,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.jbspin.2009.03.012","type":"journal-article","created":{"date-parts":[[2009,9,21]],"date-time":"2009-09-21T08:10:23Z","timestamp":1253520623000},"page":"464-473","source":"Crossref","is-referenced-by-count":101,"title":["Interferons and autoimmune disorders"],"prefix":"10.1016","volume":"76","author":[{"given":"Olivier","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2009.03.012_bib1","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nrd2422","article-title":"Interferons at age 50: past, current and future impact on biomedicine","volume":"6","author":"Borden","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jbspin.2009.03.012_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.immuni.2006.08.008","article-title":"Fifty years of interferon research: aiming at a moving target","volume":"25","author":"Vilcek","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jbspin.2009.03.012_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.immuni.2006.08.009","article-title":"Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors","volume":"25","author":"Honda","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jbspin.2009.03.012_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.coi.2008.05.009","article-title":"Intracellular DNA sensors in immunity","volume":"20","author":"Takeshita","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature04946","article-title":"Intracellular pattern recognition receptors in the host response","volume":"442","author":"Meylan","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jbspin.2009.03.012_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/art.23217","article-title":"The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions","volume":"58","author":"Roelofs","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.03.012_bib7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ng1782","article-title":"A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus","volume":"38","author":"Graham","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.jbspin.2009.03.012_bib8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/eji.200637009","article-title":"TLR pathways and IFN-regulatory factors: to each its own","volume":"37","author":"Colonna","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nm1590","article-title":"TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity","volume":"13","author":"Baccala","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jbspin.2009.03.012_bib10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nri1630","article-title":"Negative regulation of toll-like receptor-mediated immune responses","volume":"5","author":"Liew","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib11","doi-asserted-by":"crossref","first-page":"15623","DOI":"10.1073\/pnas.95.26.15623","article-title":"Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays","volume":"95","author":"Der","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2009.03.012_bib12","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2009.03.012_bib13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jbspin.2009.03.012_bib14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib15","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.4049\/jimmunol.181.3.2092","article-title":"Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages","volume":"181","author":"Qiu","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib16","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1084\/jem.189.9.1451","article-title":"Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs","volume":"189","author":"Kayagaki","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.jbspin.2009.03.012_bib17","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1002\/art.23035","article-title":"Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus","volume":"56","author":"Lee","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.03.012_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.0105-2896.2005.00252.x","article-title":"Interferons as pathogenic effectors in autoimmunity","volume":"204","author":"Baccala","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jbspin.2009.03.012_bib19","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1189\/jlb.1007676","article-title":"TGF-beta1 and IFN-gamma stimulate mouse macrophages to express BAFF via different signaling pathways","volume":"83","author":"Kim","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib20","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1182\/blood-2007-05-089086","article-title":"Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis","volume":"110","author":"Denny","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2009.03.012_bib21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1191\/096120300674499064","article-title":"Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies","volume":"9","author":"Bengtsson","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.jbspin.2009.03.012_bib22","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1126\/science.1064890","article-title":"Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus","volume":"294","author":"Blanco","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jbspin.2009.03.012_bib23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.coi.2004.09.014","article-title":"The emerging role of interferon in human systemic lupus erythematosus","volume":"16","author":"Baechler","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clim.2004.06.005","article-title":"Gene expression profiling in peripheral blood mononuclear cells from lupus patients with active and inactive disease","volume":"112","author":"Rus","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.coi.2008.06.008","article-title":"Antimicrobial peptides and self-DNA in autoimmune skin inflammation","volume":"20","author":"Gilliet","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ni1457","article-title":"Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE","volume":"8","author":"Tian","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib27","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2358","article-title":"Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases","volume":"8","author":"Gilliet","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib28","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1084\/jem.20051696","article-title":"Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8","volume":"202","author":"Vollmer","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jbspin.2009.03.012_bib29","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/eji.200838138","article-title":"Yaa autoimmune phenotypes are conferred by overexpression of TLR7","volume":"38","author":"Fairhurst","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib30","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.4049\/jimmunol.181.2.1556","article-title":"Evidence for genes in addition to Tlr7 in the Yaa translocation linked with acceleration of systemic lupus erythematosus","volume":"181","author":"Santiago-Raber","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib31","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1002\/art.11225","article-title":"Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"48","author":"Blomberg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.03.012_bib32","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/ni1412","article-title":"Nod-like proteins in immunity, inflammation and disease","volume":"7","author":"Fritz","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib33","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1002\/art.23142","article-title":"Association of an IRF5 gene functional polymorphism with Sjogren's syndrome","volume":"56","author":"Miceli-Richard","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.03.012_bib34","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/art.20998","article-title":"Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism","volume":"52","author":"Bave","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.03.012_bib35","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1002\/art.23062","article-title":"Augmented interferon-alpha pathway activation in patients with Sjogren's syndrome treated with etanercept","volume":"56","author":"Mavragani","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.03.012_bib36","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1073\/pnas.0510837103","article-title":"Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome","volume":"103","author":"Gottenberg","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2009.03.012_bib37","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/eji.200738008","article-title":"Systemic increase in type I interferon activity in Sjogren's syndrome: a putative role for plasmacytoid dendritic cells","volume":"38","author":"Wildenberg","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib38","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/eji.200738013","article-title":"Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways","volume":"38","author":"Ittah","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s10875-007-9157-0","article-title":"Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies","volume":"28","author":"Strandberg","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4049\/jimmunol.179.1.26","article-title":"Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages","volume":"179","author":"Kong","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib41","article-title":"Interferon-gamma is increased in patients with primary Sjogren's syndrome and Raynaud's phenomenon","author":"Willeke","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.03.012_bib42","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/rheumatology\/kei244","article-title":"Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients","volume":"45","author":"Tan","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2009.03.012_bib43","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/art.23486","article-title":"Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis","volume":"58","author":"Kim","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.03.012_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.imlet.2008.03.016","article-title":"Interferons and scleroderma-a new clue to understanding the pathogenesis of scleroderma?","volume":"118","author":"Coelho","year":"2008","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jbspin.2009.03.012_bib45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/art.24183","article-title":"Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis. A new perspective for pulmonary fibrosis","volume":"60","author":"Dieude","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.03.012_bib46","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib47","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20020186","article-title":"Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells","volume":"196","author":"Howard","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jbspin.2009.03.012_bib48","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.23426","article-title":"Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis","volume":"58","author":"Dieguez-Gonzalez","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.03.012_bib49","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/art.23549","article-title":"Association of STAT4 with rheumatoid arthritis: a replication study in three European populations","volume":"58","author":"Orozco","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.03.012_bib50","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.humimm.2008.06.006","article-title":"Association of a TRAF1 and a STAT4 gene polymorphism with increased risk for rheumatoid arthritis in a genetically homogeneous population","volume":"69","author":"Zervou","year":"2008","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib51","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1074-7613(04)00108-6","article-title":"Autoimmunity through cytokine-induced dendritic cell activation","volume":"20","author":"Banchereau","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jbspin.2009.03.012_bib52","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1371\/journal.pmed.0030491","article-title":"Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus","volume":"3","author":"Bauer","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.jbspin.2009.03.012_bib53","first-page":"S526","article-title":"MEDI-545, an anti-interferon alpha monoclonal antibody, shows evidence of clinical activity in systemic lupus erythematosus","volume":"56","author":"Wallace","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.03.012_bib54","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/art.20810","article-title":"Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB\u00d7NZW mice","volume":"52","author":"Dong","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.03.012_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nri1329","article-title":"Immunotherapeutic uses of CpG oligodeoxynucleotides","volume":"4","author":"Klinman","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jbspin.2009.03.012_bib56","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI19316","article-title":"Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma","volume":"115","author":"Kampmann","year":"2005","journal-title":"J Clin Invest"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X09001298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X09001298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,16]],"date-time":"2018-12-16T21:25:21Z","timestamp":1544995521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X09001298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1297319X09001298"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2009.03.012","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}